Lewy body diseases and the gut
Abstract Gastrointestinal (GI) involvement in Lewy body diseases (LBDs) has been observed since the initial descriptions of patients by James Parkinson. Recent experimental and human observational studies raise the possibility that pathogenic alpha-synuclein (⍺-syn) might develop in the GI tract and...
Saved in:
Main Authors: | Timothy R. Sampson, Malú Gámez Tansey, Andrew B. West, Rodger A. Liddle |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13024-025-00804-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An overview of methods for the treatment and diagnosis of dementia with Lewy bodies. Clinical case analysis
by: M. Š. Markevičiūtė, et al.
Published: (2020-12-01) -
Impact of physical exercise on the regulation of brain-derived neurotrophic factor in people with neurodegenerative diseases
by: Ana Romero Garavito, et al.
Published: (2025-01-01) -
Editorial: Animal models of Alzheimer's disease and other dementias: past, present, and future
by: Ines Moreno-Gonzalez, et al.
Published: (2025-01-01) -
Examining the prevention approach in National Dementia Plans from European and North American countries
by: Mattia Andreoletti, et al.
Published: (2025-01-01) -
Higher systemic immune-inflammation index is associated with increased risk of Parkinson’s disease in adults: a nationwide population-based study
by: Jiayu Zhao, et al.
Published: (2025-02-01)